Compound Report Overview
Compound Name:
DICYCLOMINE
Compound Identifier:
707761
Mol Structure 2D:
707761
Molecular Weight:
309
Formula:
C19 H35 N O2
Development Status:
US FDA Approved
SMILES:
CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| DICYCLOMINE | 213 | Sigma1 | View |
| DICYCLOMINE | 216 | Sodium Channel, Site 2 | View |
| DICYCLOMINE | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| DICYCLOMINE | 620 | Calcium Channel Type L, Benzothiazepine | View |
| DICYCLOMINE | 210 | Serotonin 5-HT6 | View |
| DICYCLOMINE | 621 | Chemokine CCR2B | View |
| DICYCLOMINE | 208 | Serotonin 5-HT4 | View |
| DICYCLOMINE | 626 | Histamine H1, Central | View |
| DICYCLOMINE | 81 | Adrenergic alpha1B | View |
| DICYCLOMINE | 148 | Histamine H2 | View |
| DICYCLOMINE | 116 | Dopamine D3 | View |
| DICYCLOMINE | 205 | Serotonin 5-HT2B | View |
| DICYCLOMINE | 214 | Sigma2 | View |
| DICYCLOMINE | 695 | Potassium Channel HERG | View |
| DICYCLOMINE | 114 | Dopamine D2L | View |
| DICYCLOMINE | 643 | CYP450-2D6 Inhibition | View |
| DICYCLOMINE | 187 | Platelet Activating Factor (PAF) | View |
| DICYCLOMINE | 171 | Muscarinic M5 | View |
| DICYCLOMINE | 170 | Muscarinic M4 | View |
| DICYCLOMINE | 169 | Muscarinic M3 | View |
| DICYCLOMINE | 167 | Muscarinic M1 | View |
| DICYCLOMINE | 168 | Muscarinic M2 | View |
| DICYCLOMINE | 206 | Serotonin 5-HT2C | View |
| DICYCLOMINE | 204 | Serotonin 5-HT2A | View |
| DICYCLOMINE | 182 | Opiate kappa | View |
| DICYCLOMINE | 113 | Dopamine D1 | View |
| DICYCLOMINE | 644 | CYP450-3A4 Inhibition | View |
| DICYCLOMINE | 84 | Adrenergic alpha2A | View |